RWS
EW icon

Retirement Wealth Solutions’s Edwards Lifesciences EW Stock Holding History

Retirement Wealth Solutions’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.26K Sell
25
-4
-14% -$335 ﹤0.01% 501
2026
Q1 		$2.32K Buy
29
+19
+190% +$1.57K ﹤0.01% 468
2025
Q4 		$853 Buy
10
+1
+11% +$82 ﹤0.01% 606
2025
Q3 		$700 Buy
+9
New +$703 ﹤0.01% 644

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Retirement Wealth Solutions's EW Position: Q2 2026 in Review

Retirement Wealth Solutions reduced its Edwards Lifesciences (EW) stake by 14% in Q2 2026, selling an estimated $335 and leaving 25 shares worth $2.26K. The position accounts for ﹤0.01% of the portfolio, ranked #501.

Retirement Wealth Solutions first reported a position in EW in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.32K in Q1 2026. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Retirement Wealth Solutions held 25 shares of Edwards Lifesciences worth $2.26K as of Q2 2026.
  • Retirement Wealth Solutions sold 4 Edwards Lifesciences shares in Q2 2026, an estimated $335.
  • Edwards Lifesciences made up ﹤0.01% of Retirement Wealth Solutions's portfolio in Q2 2026, its #501 holding.
  • Retirement Wealth Solutions first reported a position in Edwards Lifesciences in Q3 2025 and has held it in 4 quarters since.
  • Retirement Wealth Solutions's Edwards Lifesciences position peaked at $2.32K in Q1 2026.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Retirement Wealth Solutions's 13F filing for Q2 2026, filed 7 Jul 2026.